HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P-S Ho Selected Research

Leptin

7/2014Continuing weight-loss effect after topiramate discontinuation in obese persons with schizophrenia: a pilot open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P-S Ho Research Topics

Disease

1Body Weight (Weight, Body)
07/2014
1Insulin Resistance
07/2014
1Schizophrenia (Dementia Praecox)
07/2014
1Weight Loss (Weight Reduction)
07/2014
1Asthma (Bronchial Asthma)
01/2011
1Obesity
01/2011
1Sialorrhea
11/2010
1Epilepsy (Aura)
08/2010
1Treatment-Resistant Schizophrenia
08/2010

Drug/Important Bio-Agent (IBA)

1LeptinIBA
07/2014
1Glucose (Dextrose)FDA LinkGeneric
07/2014
1LipidsIBA
07/2014
1Topiramate (Topamax)FDA LinkGeneric
07/2014
1C-Reactive ProteinIBA
01/2011
1Risperidone (Risperdal Consta)FDA LinkGeneric
11/2010
1Allopurinol (Remid)FDA LinkGeneric
08/2010